Cheng Liu
Chief Executive Officer Eureka Therapeutics
Dr. Cheng Liu is the Founder, President and CEO of Eureka Therapeutics. Prior to founding Eureka, he was a Principal Scientist in antibody drug discovery at Chiron (now Novartis). With over 20 years of experience in the field, Dr. Liu holds more than 500 patents and published patent applications of which over 100 patents have issued worldwide and has authored numerous peer-reviewed papers on cancer immunotherapy.
Seminars
Tuesday 19th May 2026
Applying TCR Mimic Antibodies in T-Cell Therapy to Achieve Durable & Persistent Clinical Responses
3:00 pm
- Sharing developments in an ongoing phase 1 trial and key learnings from the clinic
- Explaining how TCR mimic armed T-cell therapy enables dual activation of CD4 and CD8 T-cells
- Discuss why CD4 engagement is critical for long-term efficacy
New Data
